Molecular mechanisms of cholangiopathy in primary biliary cirrhosis

被引:43
作者
Harada, Kenichi [1 ]
Nakanuma, Yasuni [1 ]
机构
[1] Kanazawa Univ, Dept Human Pathol, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan
关键词
apoptosis; chronic nonsuppurative destructive cholangitis; intrahepatic bile ducts; primary biliary cirrhosis; cytokines;
D O I
10.1007/s00795-006-0321-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Primary biliary cirrhosis (PBC) is histologically characterized by chronic nonsuppurative destructive cholangitis (CNSDC) and the progressive loss of intrahepatic small bile ducts. Cellular immune mechanisms involving T-cell reaction are thought to be significantly involved in the formation of CNSDC and bile duct loss. In inflamed portal tracts of PBC, CD4(+)T cells of Th1 type expressing IFN-gamma or CXCR3 are aggregated and more commonly detected around injured bile ducts than Th2-type CD4(+) T cells expressing IL-4 or CCR4, indicating that Th1-dominant cellular immunity plays a more-prominent role in recruitment of memory T-cell subsets in PBC and may be responsible for the progressive bile duct damage. Biliary epithelial apoptosis is demonstrated to be a major pathogenic process of bile duct loss in PBC. In CNSDC. several biliary apoptotic cells, an aberrant expression of Fas antigen (proapoptotic molecule) and decreased expression of bcl-2 and mcl-1 (antiapoptotic molecules) are found. although interlobular bile ducts express bcl-2 and mcl-2 but lack Fas. In addition, the upregulation of WAF1 and p53 related to biliarv apoptosis is found in biliary epithelial cells of PBC, which may be due to cell senescence in response to genotoxic damage such as oxidative stress. Several steps and mechanisms during induction and progression of cholanoitis and biliary apoptosis followed by bile duct loss are now being proposed in PBC, but future analysis of an etiopathogenesis to explain the characteristic histopathogenesis of PBC is required.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 61 条
  • [1] Cytokines in primary biliary cirrhosis
    Berg, PA
    Klein, R
    Röcken, M
    [J]. SEMINARS IN LIVER DISEASE, 1997, 17 (02) : 115 - 123
  • [2] Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its lactobacillus mimic
    Bogdanos, DP
    Baum, H
    Okamoto, M
    Montalto, P
    Sharma, UC
    Rigopoulou, EI
    Vlachogiannakos, J
    Ma, Y
    Burroughs, AK
    Vergani, D
    [J]. HEPATOLOGY, 2005, 42 (02) : 458 - 465
  • [3] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
    BOISE, LH
    GONZALEZGARCIA, M
    POSTEMA, CE
    DING, LY
    LINDSTEN, T
    TURKA, LA
    MAO, XH
    NUNEZ, G
    THOMPSON, CB
    [J]. CELL, 1993, 74 (04) : 597 - 608
  • [4] M2 MITOCHONDRIAL ANTIBODIES AND URINARY ROUGH MUTANT BACTERIA IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS AND IN PATIENTS WITH RECURRENT BACTERIURIA
    BUTLER, P
    VALLE, F
    HAMILTONMILLER, JMT
    BRUMFITT, W
    BAUM, H
    BURROUGHS, AK
    [J]. JOURNAL OF HEPATOLOGY, 1993, 17 (03) : 408 - 414
  • [5] Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes
    Celli, A
    Que, FG
    Gores, GJ
    LaRusso, NF
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1998, 275 (04): : G749 - G757
  • [6] Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma
    Celli, A
    Que, FG
    [J]. SEMINARS IN LIVER DISEASE, 1998, 18 (02) : 177 - 185
  • [7] CHARLOTTE F, 1994, AM J PATHOL, V144, P460
  • [8] Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives
    Chuang, YH
    Lian, ZX
    Cheng, CM
    Lan, RY
    Yang, GX
    Moritoki, Y
    Chiang, BL
    Ansari, AA
    Tsuneyama, K
    Coppel, RL
    Gershwin, ME
    [J]. JOURNAL OF AUTOIMMUNITY, 2005, 25 (02) : 126 - 132
  • [9] Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis
    Dienes, HP
    Lohse, AW
    Gerken, G
    Schirmacher, P
    Gallati, H
    Lohr, HF
    zumBuschenfelde, KHM
    [J]. VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1997, 431 (02): : 119 - 124
  • [10] ELDEIRY WS, 1994, CANCER RES, V54, P1169